We are live on ! Find out more
GPCM

Granite Point Capital Management Portfolio holdings

AUM $4.9M
1-Year Est. Return 38.41%
This Fund
S&P 500
This Quarter Est. Return
+2.1%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$125M
AUM Growth
-$131M
Cap. Flow
-$122M
Cap. Flow %
-97.07%
Top 10 Hldgs %
39.36%
Holding
112
New
21
Increased
21
Reduced
8
Closed
32

Top Buys

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.61M
2
AXGN icon
Axogen
AXGN
+$2.46M
3
ACRS icon
Aclaris Therapeutics
ACRS
+$2.42M
4
BAC icon
Bank of America
BAC
+$2.41M
5
HDSN
Hudson Technologies
HDSN
+$1.84M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.91M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$4.02M
3
HIMX
Himax Technologies
HIMX
+$3.25M
4
CY
Cypress Semiconductor
CY
+$2.13M
5
MEET
The Meet Group, Inc. Common Stock
MEET
+$1.81M

Sector Composition

Rank Sector Weight
1 Healthcare 26.12%
2 Consumer Discretionary 12.52%
3 Technology 11.2%
4 Communication Services 9.58%
5 Financials 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HEWG
51
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
$775K 0.62%
+30,000
New +$734K
MRVL icon
52
Marvell Technology
MRVL
$168B
$768K 0.61%
55,350
– –
WB icon
53
Weibo
WB
$2B
$706K 0.56%
+17,400
New +$830K
COE
54
51Talk Online Education Group
COE
$105M
$658K 0.52%
10,583
+583
+6% +$37.5K
P
55
DELISTED
Pandora Media Inc
P
$652K 0.52%
+50,000
New +$620K
SCTL
56
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$613K 0.49%
84,740
+4,460
+6% +$30.5K
YANG icon
57
Direxion Daily FTSE China Bear 3X ETF
YANG
$82.6M
$507K 0.4%
+150
New +$460K
SCYX icon
58
SCYNEXIS
SCYX
$48.1M
$502K 0.4%
1,969
– –
YUMC icon
59
Yum China
YUMC
$16.5B
$496K 0.4%
+19,000
New +$517K
DXJ icon
60
WisdomTree Japan Hedged Equity Fund
DXJ
$7.08B
$495K 0.39%
+10,000
New +$470K
EBIX
61
DELISTED
Ebix Inc
EBIX
$485K 0.39%
8,500
– –
FENG
62
Phoenix New Media
FENG
$17.7M
$470K 0.37%
+24,965
New +$551K
CY
63
DELISTED
Cypress Semiconductor
CY
$458K 0.37%
40,000
-193,800
-83% -$2.13M
RNG icon
64
RingCentral
RNG
$4.66B
$431K 0.34%
20,925
– –
VNET
65
VNET Group
VNET
$2.04B
$396K 0.32%
56,500
+5,000
+10% +$37.4K
ADVM
66
DELISTED
Adverum Biotechnologies
ADVM
$377K 0.3%
+13,000
New +$425K
CBPO
67
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$376K 0.3%
3,500
-10,000
-74% -$1.17M
CYD icon
68
China Yuchai International
CYD
$1.77B
$320K 0.26%
+23,171
New +$279K
BZUN
69
Baozun
BZUN
$167M
$302K 0.24%
+25,000
New +$360K
ENPH icon
70
Enphase Energy
ENPH
$4.96B
$296K 0.24%
293,234
-506,766
-63% -$581K
LCTX icon
71
Lineage Cell Therapeutics
LCTX
$269M
$284K 0.23%
90,059
– –
DCOY
72
Decoy Therapeutics
DCOY
$2.19M
– –
0
– –
EHIC
73
DELISTED
eHi Car Services Limited
EHIC
$260K 0.21%
28,700
+17,900
+166% +$180K
CYOU
74
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$250K 0.2%
11,795
– –
MEDP icon
75
Medpace
MEDP
$16.1B
$243K 0.19%
6,750
– –
1 2
3
4 5

Similar funds

MAM
Moelis Asset Management New York $5.32M AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
SM
SG3 Management Dorado, Puerto Rico $6.45K AUM 61.81% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

Granite Point Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Granite Point Capital Management held 112 positions worth $125M, down 51% from $256M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Granite Point Capital Management withdrew a net $122M in Q4 2016, closing 32 positions and reducing 8 holdings. Its most notable exit was Apple, an estimated $4.91M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Granite Point Capital Management opened a new position in Alnylam Pharmaceuticals worth $4.12M.

  • Granite Point Capital Management's largest Q4 2016 buy was Alnylam Pharmaceuticals: 110,000 shares worth $4.12M.
  • Granite Point Capital Management added most to Axogen in Q4 2016, an estimated $2.46M increase.
  • Granite Point Capital Management's biggest Q4 2016 reduction was Sarepta Therapeutics, cutting an estimated $4.02M.
  • Granite Point Capital Management fully exited Apple in Q4 2016, selling an estimated $4.91M.
  • Granite Point Capital Management's ten largest holdings make up 39% of its $125M portfolio in Q4 2016.
  • Granite Point Capital Management opened 21 new positions and closed 32 in Q4 2016.
  • Granite Point Capital Management's portfolio value fell 51% quarter-over-quarter to $125M.

Based on Granite Point Capital Management's 13F filing for Q4 2016, filed 7 Feb 2017.